Connecting for innovation and impact for all in global health
- This event has passed.
What Keeps Innovative Technologies From Patients?
January 8 @ 9:00 am
What are the challenges in achieving Medicare reimbursement for Breakthough Devices? Stanford Biodesign are bringing together a panel of health policy experts and entrepreneurs to discuss Breakthrough Device Designation and the coverage and payment programs linked to this designation. This will be an insightful conversation facilitated by Sandra Waugh Ruggles, PhD, Stanford Biodesign’s director of policy research. Panelists:
- Nancy Isaac, JD, Director, Regulatory Policy, Stanford Mussallem Center for Biodesign
- Dan Waldmann, JD, EVP, Health Policy & Reimbursement, Medical Device Manufacturers Association
- Rudy Missmar, JD, Principal, FHP Strategies
- Shri Raghunathan, PhD, Founder & CEO, Noctrix Health